Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
Soudeh Ghafouri‐Fard, Mahdi Gholipour, Mohammad Taheri
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

miRNAs as potential game-changers in melanoma: A comprehensive review
Gamil M. Abd‐Allah, Ahmed Ismail, Hesham A. El-Mahdy, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154424-154424
Closed Access | Times Cited: 54
Unraveling the Wide Spectrum of Melanoma Biomarkers
Antonios Revythis, Sidrah Shah, M Kutka, et al.
Diagnostics (2021) Vol. 11, Iss. 8, pp. 1341-1341
Open Access | Times Cited: 68
Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management
Laura Maria Gosman, Dana Antonia Țăpoi, Mariana Costache
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15881-15881
Open Access | Times Cited: 39
Role of miRNA in Melanoma Development and Progression
Agata Poniewierska-Baran, Sylwia Słuczanowska-Głąbowska, Paulina Małkowska, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 201-201
Open Access | Times Cited: 38
microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance
Mehdi Fattahi, Saeid Shahrabi, Fatemeh Saadatpour, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 125863-125863
Closed Access | Times Cited: 38
Functional significance of tRNA-derived fragments in sustained proliferation of tumor cells
Mohammad Salehi, Mohammad Javad Kamali, Zahra Ashuori, et al.
Gene Reports (2024) Vol. 35, pp. 101901-101901
Closed Access | Times Cited: 10
Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach
Elena Ricciardi, Elena Giordani, Giovanna Ziccheddu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4014-4014
Open Access | Times Cited: 19
MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection—Narrative Review
Agata Poniewierska-Baran, Łukasz Zadroga, Edo Danilyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5386-5386
Open Access | Times Cited: 17
Diagnostic Power of MicroRNAs in Melanoma: Integrating Machine Learning for Enhanced Accuracy and Pathway Analysis
Haniyeh Rafiepoor, Alireza Ghorbankhanloo, Soroush Soleimani Dorcheh, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Analysis of MicroRNA Expression in Specimens From Patients With Cutaneous Melanoma
J Stefanová, N V Porhanova, Р. А. Мурашко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 49-55
Open Access
The Role of Extracellular Vesicles in Melanoma Progression
Evelyn Lattmann, Mitchell P. Levesque
Cancers (2022) Vol. 14, Iss. 13, pp. 3086-3086
Open Access | Times Cited: 21
MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma
Manal S. Fawzy, Afaf T. Ibrahiem, Naglaa A. Bayomy, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1205-1205
Open Access | Times Cited: 11
Expression of microRNA-16-5b, microRNA-27a, -34a-5p, -125b, -181 and -193b in cutaneous melanoma tissue
V. A. Bogdanova, Л. В. Спирина, S. Yu. Chizhevskaya
Bone and soft tissue sarcomas tumors of the skin (2025) Vol. 16, Iss. 4, pp. 100-105
Closed Access
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma
Ciro Francesco Ruggiero, Luigi Fattore, Irene Terrenato, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7420-7430
Open Access | Times Cited: 18
Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View
Aigli Korfiati, Katerina Grafanaki, George Kyriakopoulos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1299-1299
Open Access | Times Cited: 16
Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment
Qiang Ye, Zi Li, Yang Li, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 80-80
Open Access | Times Cited: 16
Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders
Austin Lui, Timothy Do, Omar Alzayat, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 426-426
Open Access | Times Cited: 3
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition
Luca Ponzone, Valentina Audrito, Claudia Landi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective
Elisabetta Fratta, Giorgio Giurato, R. Guerrieri, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Role of a Polyphenol-Enriched Blueberry Preparation on Inhibition of Melanoma Cancer Stem Cells and Modulation of MicroRNAs
Nawal Alsadi, Nour Yahfoufi, Carolyn Nessim, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 193-193
Open Access | Times Cited: 2
Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma
María Belén García‐Ortega, Ernesto Aparicio‐Puerta, Carmen Griñán‐Lisón, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3666-3666
Open Access | Times Cited: 6
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
Lauretta Levati, Cristian Bassi, Simona Mastroeni, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3706-3706
Open Access | Times Cited: 8
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research
Claudia Ceci, Celia García-Chico, Maria Grazia Atzori, et al.
Journal of Cancer (2023) Vol. 15, Iss. 1, pp. 1-19
Open Access | Times Cited: 4
TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma
Bruna Fernandes Carvalho, Gabriela Vilas Bôas Gomez, Juliana Carron, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2868-2868
Open Access | Times Cited: 1
A New Approach to Melanoma Treatment: microRNAs
Süleyman İlhan, Ferdi Oğuz, Harika Atmaca
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 16, pp. 1362-1376
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top